All Relations between Serotonergic psychedelics and cannabinoids

Publication Sentence Publish Date Extraction Date Species
B E Smink, B Ruiter, K J Lusthof, J J de Gier, D R A Uges, A C G Egbert. Drug use and the severity of a traffic accident. Accident; analysis and prevention. vol 37. issue 3. 2005-07-21. PMID:15784196. all the blood samples obtained after the accident were screened for the presence of alcohol, illicit drugs (opiates, amphetamines and amphetamine-like substances, cocaine and metabolites, methadone, cannabinoids) and medicinal drugs (benzodiazepines, barbiturates and tricyclic antidepressants). 2005-07-21 2023-08-12 Not clear
Peer K Lilleng, Lars Ivar Mehlum, Liliana Bachs, Inge Moril. Deaths after intravenous misuse of transdermal fentanyl. Journal of forensic sciences. vol 49. issue 6. 2005-01-21. PMID:15568716. post-mortem femoral blood was screened for amphetamines, cannabinoids, cocaine, and opioids with immunological methods (emit ii) and further with headspace gas chromatography for alcohol and with liquid chromatography mass spectrometry (lc-ms) for different drugs, including fentanyl. 2005-01-21 2023-08-12 Not clear
Olaf H Drumme. Postmortem toxicology of drugs of abuse. Forensic science international. vol 142. issue 2-3. 2004-09-02. PMID:15172074. this article reviews particular toxicological issues associated with the more common drugs of abuse such as the amphetamines, cannabinoids, cocaine, opioids and the benzodiazepines. 2004-09-02 2023-08-12 Not clear
Lars Kroener, Frank Musshoff, Burkhard Made. Evaluation of immunochemical drug screenings of whole blood samples. A retrospective optimization of cutoff levels after confirmation-analysis on GC-MS and HPLC-DAD. Journal of analytical toxicology. vol 27. issue 4. 2004-03-08. PMID:12820742. six groups of illicit drugs (opiates, cannabinoids, amphetamines, cocain and benzoylecgonine, benzodiazepines, and methadone) were determined by using the homogenous assays adx and cedia dau and compared with the results produced by means of the inhomogenous assays mtp and pyxis 24. 2004-03-08 2023-08-12 Not clear
Lars Kroener, Frank Musshoff, Burkhard Made. Evaluation of immunochemical drug screenings of whole blood samples. A retrospective optimization of cutoff levels after confirmation-analysis on GC-MS and HPLC-DAD. Journal of analytical toxicology. vol 27. issue 4. 2004-03-08. PMID:12820742. the evaluation of the pyxis 24 resulted in specificities of 70-96% (benzodiazepines and amphetamines) and sensitivities of 75% (amphetamines) up to 100% (cannabinoids and methadone), respectively. 2004-03-08 2023-08-12 Not clear
H Kupferschmid. [Acute drug poisoning]. Therapeutische Umschau. Revue therapeutique. vol 60. issue 6. 2004-01-05. PMID:12848070. compounds of major importance are cannabinoids, opiates, cocaine, amphetamines, ecstasy, hallucinogens, phencyclidine, gammahydroxybutyrate, volatile nitrites, solvents, and nitrous oxide. 2004-01-05 2023-08-12 Not clear
P Mura, P Kintz, B Ludes, J M Gaulier, P Marquet, S Martin-Dupont, F Vincent, A Kaddour, J P Goullé, J Nouveau, M Moulsma, S Tilhet-Coartet, O Pourra. Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic science international. vol 133. issue 1-2. 2003-07-29. PMID:12742692. a collaborative case-control study was conducted in france in order to determine the prevalence of alcohol, cannabinoids, opiates, cocaine metabolites, amphetamines and therapeutic psychoactive drugs in blood samples from drivers injured in road accidents and to compare these values with those of a control population. 2003-07-29 2023-08-12 human
Frank Musshoff, Dirk W Lachenmeier, Burkhard Made. Methadone substitution: medicolegal problems in Germany. Forensic science international. vol 133. issue 1-2. 2003-07-29. PMID:12742698. in most of the cases, up to five additional drugs were also being taken: benzodiazepines (61%), ethanol (40%), morphine (39%), cannabinoids (35%), cocaine (28%), anti-depressants (3%), and amphetamines (2%). 2003-07-29 2023-08-12 Not clear
Carmen Jurado, Hans Sach. Proficiency test for the analysis of hair for drugs of abuse, organized by the Society of Hair Testing. Forensic science international. vol 133. issue 1-2. 2003-07-29. PMID:12742707. participants were requested to analyze the samples following the standard procedure used routinely in their laboratories.the compounds present in the samples included opiates, cocaine and metabolite, cannabinoids and amphetamines. 2003-07-29 2023-08-12 human
Carmen Jurado, Hans Sach. Proficiency test for the analysis of hair for drugs of abuse, organized by the Society of Hair Testing. Forensic science international. vol 133. issue 1-2. 2003-07-29. PMID:12742707. all the laboratories analyzed opiates, cocaine and benzoylecgonine (be); only 10 analyzed amphetamines, and 9 cannabinoids. 2003-07-29 2023-08-12 human
Yukiko Hino, Ilkka Ojanperä, Ilpo Rasanen, Erkki Vuor. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood. Forensic science international. vol 131. issue 2-3. 2003-05-20. PMID:12590054. performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood. 2003-05-20 2023-08-12 Not clear
Yukiko Hino, Ilkka Ojanperä, Ilpo Rasanen, Erkki Vuor. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood. Forensic science international. vol 131. issue 2-3. 2003-05-20. PMID:12590054. blood samples known to be positive or negative for opiates, cannabinoids or amphetamines by gas chromatography-mass spectrometry (gc-ms) were analysed by emit ii plus and emit d.a.u., syva rapidtest and triage 8 after acetone precipitation. 2003-05-20 2023-08-12 Not clear
Yukiko Hino, Ilkka Ojanperä, Ilpo Rasanen, Erkki Vuor. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood. Forensic science international. vol 131. issue 2-3. 2003-05-20. PMID:12590054. the sensitivities of the modified emit method for opiates, cannabinoids and amphetamines were 100, 86 and 98%, respectively, whereas the values were below 86% with the other methods. 2003-05-20 2023-08-12 Not clear
Yukiko Hino, Ilkka Ojanperä, Ilpo Rasanen, Erkki Vuor. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood. Forensic science international. vol 131. issue 2-3. 2003-05-20. PMID:12590054. the specificities of all immunoassay methods for opiates and cannabinoids were 83% or above but 51-85% for amphetamines. 2003-05-20 2023-08-12 Not clear
Javier Padilla, Ma Cristina Eguíalis, Francisco Mendoza, Victor A Santos, Patricia Ojed. Monoclonal antibody urine assay for amphetamines, cocaine and cannabinoids: a pilot study of Mexican athletes. Proceedings of the Western Pharmacology Society. vol 45. 2003-05-13. PMID:12434578. monoclonal antibody urine assay for amphetamines, cocaine and cannabinoids: a pilot study of mexican athletes. 2003-05-13 2023-08-12 Not clear
Dirk W Lachenmeier, Lars Kroener, Frank Musshoff, Burkhard Made. Application of tandem mass spectrometry combined with gas chromatography and headspace solid-phase dynamic extraction for the determination of drugs of abuse in hair samples. Rapid communications in mass spectrometry : RCM. vol 17. issue 5. 2003-04-09. PMID:12590396. the analytes are absorbed from the sample headspace directly into a hollow needle with an internal coating of polydimethylsiloxane by repeated aspirate/dispense cycles.the hs-spde/gc/ms/ms procedure was applied to the analysis of methadone, the trimethylsilyl derivatives of cannabinoids and the trifluoroacetyl derivatives of amphetamines and designer drugs. 2003-04-09 2023-08-12 Not clear
Harald Schütz, Jan Christoph Gotta, Freidoon Erdmann, Manfred Risse, Günter Weile. Simultaneous screening and detection of drugs in small blood samples and bloodstains. Forensic science international. vol 126. issue 3. 2002-11-07. PMID:12062939. the detection limits are in the order of 1.62-4.10 ng/50 microl spot (amphetamines), 0.15-0.82 ng/50 microl spot (cannabinoids), 1.67-4.70 ng/50 microl spot (cocaine and derivatives) and 4.53-4.91 ng/50 microl spot (opiates) and the correlation factors are between 0.9957 and 0.9999. 2002-11-07 2023-08-12 Not clear
Albert D Fraser, Jiri Zamecni. Substance abuse monitoring by the Correctional Service of Canada. Therapeutic drug monitoring. vol 24. issue 1. 2002-04-23. PMID:11805743. urine specimens were tested for drugs of abuse and prescription drugs including amphetamines, cannabinoids, cocaine metabolite, opiates, phencyclidine, benzodiazepines, methyl phenidate, meperidine, pentazocine and fluoxetine by immunoassay screening followed by gc-ms confirmation. 2002-04-23 2023-08-12 human
Jean-Paul Selten, Ingrid J Bosman, Douwe de Boer, Natalie D Veen, Yolanda van der Graaf, Robert A A Maes, René S Kah. Hair analysis for cannabinoids and amphetamines in a psychosis incidence study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 12. issue 1. 2002-03-26. PMID:11788237. hair analysis for cannabinoids and amphetamines in a psychosis incidence study. 2002-03-26 2023-08-12 Not clear
Jean-Paul Selten, Ingrid J Bosman, Douwe de Boer, Natalie D Veen, Yolanda van der Graaf, Robert A A Maes, René S Kah. Hair analysis for cannabinoids and amphetamines in a psychosis incidence study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 12. issue 1. 2002-03-26. PMID:11788237. we examined the usefulness of hair analysis to detect the use of cannabinoids or amphetamines during this period. 2002-03-26 2023-08-12 Not clear